ClinicalTrials.gg
CompletedNCT07891351Updated Oct 23, 2026

Effects Of Sensor Assisted Neuro-muscular Exercise Vs Electrical Stimulation On Bio-mechnical And Functional Parameters In Grade II And III Knee Osteoarthritis.

An interventional study of Sensory-Assisted Neuromuscular Exercise and Electrical stimulation in Knee Arthritis Osteoarthritis and Neuromuscular Adaptations, sponsored by Ziauddin University. Completed at 1 site in Pakistan. Open to participants aged 40 Years to 60 Years. Per ClinicalTrials.gov, last updated 2026-10-23.

Sponsored by Ziauddin University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 5 years 8 months after the study started (first participant enrolled Feb 2021, registered Oct 2026).
Updated Oct 23, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
40
Allocation
Randomized
Ages
40 Years to 60 Years
Sex
All
01

Study summary

This two-arm randomized controlled trial compared Sensory-Assisted Neuromuscular Exercise (Group A) with Electrical Stimulation (Group B) in 40 adults aged 40-65 with Kellgren-Lawrence Grade II-III knee osteoarthritis, recruited from Ziauddin Hospital and Nemat Begum Hamdard Hospital. Both interventions were given three times a week for eight weeks, with outcomes assessed at baseline, week 8, and week 12 across eighteen variables covering pain, stiffness, function, range of motion, muscle activation, strength, alignment, and quality of life. Both groups improved significantly, but the neuromuscular exercise group outperformed electrical stimulation on most outcomes by week 12. Only the HKA alignment angle remained unchanged in both groups, as expected for a fixed skeletal measure. The authors conclude that neuromuscular exercise should be prioritized as a first-line conservative treatment, with electrical stimulation serving as an adjunct.

Read the detailed description

Background: Knee osteoarthritis (KOA) is the most prevalent form of arthritis worldwide, imposing a substantial and growing burden on physical function and quality of life. While therapeutic exercise and electrical stimulation are both widely used conservative treatments, direct comparative evidence spanning pain, biomechanical, neuromuscular, and quality-of-life outcomes within a single trial remains limited.

Objective: This study compared the effects of Sensory-Assisted Neuromuscular Exercise (Group A) and Electrical Stimulation (Group B) on pain, stiffness, physical function, range of motion, neuromuscular activation, muscular strength, mechanical alignment, and knee-related quality of life in adults with Kellgren-Lawrence Grade II-III knee osteoarthritis.

Methods: A two-arm, parallel-group randomized controlled trial was conducted at Ziauddin Hospital and Nemat Begum Hamdard Hospital. Forty participants (aged 40-65 years) were randomized 1:1 to Group A or Group B (n = 20 each) using a computer-generated sequence with allocation concealment. Both interventions were delivered three times weekly for eight weeks, with outcomes assessed at baseline (T0), post-treatment (T1, week 8), and follow-up (T2, week 12) across eighteen variables, including the Numeric Rating Scale, WOMAC, KOOS, surface electromyography, dynamometry, goniometry, and Hip-Knee-Ankle (HKA) radiographic alignment. Data were analyzed using repeated-measures ANOVA/Friedman tests (within-group) and independent-samples t-tests/Mann-Whitney U tests (between-group).

02

Conditions studied

  • Knee Arthritis Osteoarthritis
  • Neuromuscular Adaptations

Keywords

  • Knee osteoarthritis
  • neuromuscular exercise
  • electrical stimulation
  • randomized controlled trial
03

In context

Osteoarthritis, Knee

3,391 studies on the registry are indexed under Osteoarthritis, Knee; 628 are open to participants now.

This study's enrollment of 40 is below the median of 69 across 2,808 interventional studies indexed under Osteoarthritis, Knee.

Browse Osteoarthritis, Knee studies →

Lead sponsor

Ziauddin University is the lead sponsor of 51 studies on the registry; 9 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
40 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosis of knee osteoarthritis, Kellgren-Lawrence Grade II or III
  • Age 40 to 65 years
  • Medically stable condition
  • Willing to participate and able to provide written informed consent
  • Able to understand and follow instructions
  • Available to attend regular treatment sessions (three times weekly for 8 weeks)

Exclusion criteria

Exclusion Criteria:

  • Knee surgery or knee injury within the last six months
  • Other musculoskeletal or neurological conditions affecting the lower limb
  • Uncontrolled cardiovascular or metabolic disease
  • Pregnancy
  • Allergy or skin sensitivity preventing electrode application
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
40 participants (actual)

Study arms

  • Experimental
    Sensory-Assisted Neuromuscular Exercise

    Sensory-assisted neuromuscular exercise, three sessions per week for 8 weeks.

    Other: Electrical stimulation

  • Active comparator
    Electrical Stimulation

    Electrical stimulation, three sessions per week for 8 weeks.

    Other: Sensory-Assisted Neuromuscular Exercise

Interventions

  • OtherSensory-Assisted Neuromuscular Exercise

    Sensory-assisted neuromuscular exercise, three sessions per week for 8 weeks.

  • OtherElectrical stimulation

    Electrical stimulation, three sessions per week for 8 weeks.

06

What researchers measure

Primary outcomes

  1. Knee Joint Alignment Measured by Hip-Knee-Ankle (HKA) Angle on Full-Leg Standing Radiograph

    Frontal-plane mechanical alignment of the affected knee, measured on a full-length standing radiograph. The HKA angle is the angle between the femoral mechanical axis (centre of femoral head to centre of knee) and the tibial mechanical axis (centre of knee to centre of ankle). It is reported in degrees of deviation from neutral (0° = neutral alignment). Higher values indicate greater malalignment.

    Time frame: Baseline, Week 8, and Week 12

Secondary outcomes

  1. Knee Pain Intensity Measured by Numeric Rating Scale (NRS)

    Knee pain intensity measured on the 11-point Numeric Rating Scale (0 = no pain, 10 = worst imaginable pain). Lower scores indicate less pain.

    Time frame: Baseline, Week 8, and Week 12

  2. WOMAC Pain, Stiffness, Physical Function, and Total Scores

    Western Ontario and McMaster Universities Osteoarthritis Index, assessing pain (0-20), stiffness (0-8), and physical function (0-68), with a total score of 0-96. Higher scores indicate worse symptoms and function.

    Time frame: Baseline, Week 8, and Week 1

  3. Knee Flexion Range of Motion Measured by Digital Goniometer

    Active knee flexion range of motion of the affected knee, measured in degrees with a digital goniometer by a blinded physiotherapist. Higher values indicate better mobility.

    Time frame: Baseline, Week 8, and Week 12

  4. Knee Extension Deficit Measured by Digital Goniometer

    Loss of full knee extension of the affected knee, measured in degrees with a digital goniometer by a blinded physiotherapist (0° = full extension). Lower values indicate a better outcome.

    Time frame: Baseline, Week 8, and Week 12

  5. Vastus Medialis Muscle Activation Measured by Surface Electromyography (sEMG)

    Muscle activation of the vastus medialis, recorded with surface EMG during a standardized contraction. Reported as amplitude in \[µV / %MVIC\]. Higher values indicate greater activation.

    Time frame: Baseline, Week 8, and Week 12

  6. Vastus Lateralis Muscle Activation Activation Measured by Surface Electromyography (sEMG)

    Muscle activation of the vastus lateralis, recorded with surface EMG during a standardized contraction. Reported as amplitude in \[µV / %MVIC\]. Higher values indicate greater activation

    Time frame: Baseline, Week 8, and Week 12

  7. Hamstring Muscle Strength Measured by Hand-Held Dynamometer

    Maximal isometric knee flexor strength of the affected limb, measured with a hand-held dynamometer, in \[N / kg\]. Higher values indicate greater strength.

    Time frame: Baseline, Week 8, and Week 12

  8. Quadriceps Muscle Strength Measured by Hand-Held Dynamometer

    Maximal isometric knee extensor strength of the affected limb, measured with a hand-held dynamometer, in \[N / kg\]. Higher values indicate greater strength

    Time frame: Baseline, Week 8, and Week 12

  9. Knee Injury and Osteoarthritis Outcome Score (KOOS)

    KOOS subscales of Pain, Symptoms, Activities of Daily Living, Sport/Recreation, and Knee-Related Quality of Life, each scored 0-100. Higher scores indicate fewer problems and better quality of life.

    Time frame: Baseline, Week 8, and Week 12

07

Study locations

1 site
  • Ziauddin University
    Karachi, Sindh 74600, Pakistan
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2021 to primary completion in Jan 2026, 59 months.

Of 1,143 non-industry interventional studies with no phase under Osteoarthritis, Knee, half reached primary completion within 18 months of starting (the median), counting those still running; a quarter within 8 and three quarters within 36. This study's 59 months is above that.

Counting every sponsor, half of 1,285 studies reached it within 18 months; a quarter within 8 and three quarters within 36.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 15, 2026
First posted
Oct 23, 2026
StartActual
Feb 1, 2021
Primary completionActual
Jan 12, 2026
CompletionActual
Feb 12, 2026
Last update
Oct 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 23, 2026
Show all 1 update
  1. Oct 23, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07891351
Lead sponsor
Ziauddin University
Responsible party
Ammanullah khan (principal investigator, Ziauddin University) — Principal investigator
First posted
Oct 23, 2026
Start date
Feb 1, 2021
Primary completion
Jan 12, 2026
Completion
Feb 12, 2026
Last update
Oct 23, 2026

Oversight

Data monitoring committee
Yes
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion